Journal of Clinical Lipidology

Papers
(The H4-Index of Journal of Clinical Lipidology is 30. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2022-08-01 to 2026-08-01.)
ArticleCitations
Comparison of virtual vs face-to-face medical nutrition therapy in patients with hyperlipidemia285
Hypercoagulability or coronary artery disease? Polygenic risk score unveils the mystery150
Effective treatment of statin- and ezetimibe-resistant hyperlipidemia in a patient with active membranous nephrotic syndrome using a PCSK9 inhibitor108
Assessment of health disparities in secondary ASCVD risk prevention in the elderly population in Greece100
Lipoprotein(a) concentrations across a global cross-sectional registry98
Disparities in statin use among individuals with and without cancer history across atherosclerotic cardiovascular disease risk categories92
Genetic mutations and associated phenotypes in familial hypercholesterolemia: A biobank study85
Care of youth with lipid disorders: A brief provider survey80
†Role of DNA methylation on 15-Lipoxygenase-1 gene expression in Osteoarthritis72
Lower Activity of Cholesteryl Ester Transfer protein (CETP) and the Risk of Dementia: A Mendelian Randomization Analysis69
From the Editors: New insights into lipid disorders in children and adolescents as well as cardiovascular benefits of pharmacotherapy for weight loss63
News from NLA63
Prevalence of Lipoprotein(a) Measurements in Patients with or at Risk of Cardiovascular Disease50
The impact of genetic testing on physician practice in specialized cardiovascular clinics49
Niacin (Niacin) and clinical utility, don't be misled by recent niacin (Niacin) metabolite report49
Impact of providing genetics-based future cardiovascular risk on LDL-C in patients with familial hypercholesterolemia48
Healthcare utilization and expenditures among adults with severe hypertriglyceridemia in US clinical practice48
Inflammation and cardiometabolic disease in South Asians: The fire and fire tenders47
Exciting new developments in clinical lipidology: Updates from the Food and Drug Administration and the American Heart Association45
Achievement of low-density lipoprotein cholesterol thresholds in very high-risk atherosclerotic cardiovascular disease45
Reanalysis of the impact of omega-3 supplementation on lipoprotein-associated phospholipase A2 mass and activity: A systematic review and meta-analysis of randomized controlled trials44
Impact of Dose of Statins on LDL-C Goal Attainment in ASCVD Patients at a Tertiary Care Centre41
Uncovering Multifactorial Genetics: A Case Report of Severe Familial Hypercholesterolemia with Suspected Oligogenic Factors in a Female Preschooler40
Impact of Cardiovascular Prevention Clinic Attendance on Lipid Management in First-Degree Relatives of Patients with Premature Cardiovascular Disease36
Obicetrapib CETP Inhibition Remodels HDL2 and Raises ApoM, S1P, ApoA1 Monomers, Boosting Plasma Xanthophyll and Carotenoid Levels36
Quantifying the 'Lp(a) Floor': ApoB-Guided Identification of Lp(a)-Dominant Atherogenic Risk35
Lipoprotein lipase DNA methylation in the adipose tissue of patients with persistent chylomicronemia35
Managing hypercholesterolemia in adults older than 75 years without a history of atherosclerotic cardiovascular disease: An Expert Clinical Consensus from the National Lipid Association and the Americ34
Lipoprotein(a) levels in children with homozygous familial hypercholesterolaemia: A cross-sectional study34
Low-attenuation plaque-mediated NSTEMI in a patient with sarcoidosis and high Lp(a)33
Assessment and management of statin-associated muscle symptoms (SAMS): A clinical perspective from the National Lipid Association30
1.2532351016998